Brief: Evolva Turns To FY Gross Loss Of CHF 1.9 Mln

EvoNext Holdings SA

25/02/2021 06:13

Feb 25 (Reuters) - EVOLVA HOLDING SA  EVE.S :
    * REPORTS FULL YEAR RESULTS FOR 2020, WITH SIGNIFICANT
INCREASE IN
CUSTOMER DEMAND FOR HEALTH INGREDIENTS AND PRODUCT EXPANSION
    * FY ADJUSTED EBITDA LOSS -14.1 MILLION CHF VERSUS -18.4
MILLION
CHF LOSS YEAR AGO
    * FY TOTAL ORDER INTAKE EXCEEDED CHF 10M FOR FIRST TIME
(+71% OVER
2019 AND AN ORDER BACKLOG OF CHF 3.6M)
    * 2021 GUIDANCE: REPORTED EBITDA AND OPERATING FREE CASH
FLOW ARE
EXPECTED TO BE AROUND 2020 LEVELS DUE TO DELAYS AND INVESTMENTS
IN SCALING UP MANUFACTURING, WHICH WILL RESULT IN EXTRAORDINARY
COSTS OF CHF 6.1M
    * FY GROSS PROFIT DECREASED FROM CHF 5.4M IN 2019 TO CHF
-1.9M,
MAINLY AS A FUNCTION OF COMPLETION OF BARDA PROJECT, WHICH
GENERATED A SIGNIFICANT GROSS PROFIT IN 2019.
    * FY EBITDA CAME IN AT A LOSS OF -16.7M CHF (-27% OVER 2019)

Source text for Eikon:  ID:nEQc53Snga 
Further company coverage:  EVE.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))